Wednesday, October 21, 2009

Shares fall on osteoporosis drug woes, lackluster sales - MarketWatch


Shares fall on osteoporosis drug woes, lackluster sales
MarketWatch
Amgen shares were down 6% at $56.16 in after-hours trading. The Thousand Oaks, Calif.-based biotech giant posted net income of $1.39 billion, ...

and more »
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)